U.S. Continuous Glucose Monitoring (CGM) Market Size By Demography (Child population, Adult population), By Testing Type (Stomach, Back of the arm), By End-Use (Split Hospitals, Home care), And Forecast

U.S. Continuous Glucose Monitoring (CGM) Market Size And Forecast

U.S. Continuous Glucose Monitoring (CGM) Market size was valued at USD 5,433.29 Million in 2023 and is projected to reach USD 20,751.15 Million by 2030, growing at a CAGR of 21.08% from 2024 to 2030.

The rising cases of diabetes and the growing demand for more advanced glucose monitoring devices have led to notable expansion and innovation in the continuous glucose monitoring market in the United States in recent years. The U.S. Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

U.S. Continuous Glucose Monitoring (CGM) Market Definition

Continuous Glucose Monitoring (CGM) is a game-changing device that has transformed how people with diabetes control their disease. This cutting-edge device delivers real-time data on blood glucose levels, allowing for more precise and proactive diabetes control. Continuous Glucose Monitoring (CGM) is a cutting-edge medical technique that continually monitors blood glucose levels during the day and night. It provides real-time data on glucose concentrations and trends, allowing diabetics to make educated decisions regarding their medication, nutrition, and lifestyle. CGM devices are made up of a sensor that is implanted beneath the skin, a transmitter, and a receiver or smartphone app that shows glucose information.

U.S. Continuous Glucose Monitoring (CGM) Market Overview

Continuous Glucose Monitoring (CGM) is a game-changing technology that has changed the diabetes management environment. CGM enables people with diabetes to take charge of their health, make educated decisions, and live a better life by delivering real-time data on glucose levels. This entire system, which consists of a sensor, transmitter, receiver or smartphone app, data analysis tools, and alerts, has significantly improved diabetes treatment by increasing glucose control, lowering the risk of hypoglycemia and hyperglycemia, and boosting general well-being.

The rising cases of diabetes and the growing demand for more advanced glucose monitoring devices have led to notable expansion and innovation in the continuous glucose monitoring market in the United States in recent years. Continuous glucose monitoring is a revolutionary technique that continually and in real-time measures blood glucose levels, giving vital information for managing diabetes. The market has undergone tremendous growth and change in the last few years as a result of advancements in technology, an increase in the number of people with diabetes, and growing awareness of the advantages of CGM. The major driver of this expansion is the increased prevalence of diabetes in the United States.

Diabetes affects 37.3 million people (11.3% of the US population), or one out of every 10 Americans, according to the Centers for Disease Control and Prevention (CDC). Because of this high prevalence, there is an increasing demand for better glucose monitoring technology, such as CGMs. Furthermore, both healthcare providers and individuals at risk are becoming more aware of the importance of blood glucose management. This has resulted in more frequent screening and earlier diabetes diagnosis, increasing demand for CGMs. The high cost of CGM devices has been a key restraint in the U.S. Continuous Glucose Monitoring (CGM) Market. These gadgets can be costly, and not all insurance policies will pay the entire cost. This can be a hurdle for people with diabetes who want to adopt CGM devices.

U.S. Continuous Glucose Monitoring (CGM) Market Segmentation Analysis

The U.S. Continuous Glucose Monitoring (CGM) Market is segmented on the basis of Demography, Testing Type, and End-Use.

U.S. Continuous Glucose Monitoring (CGM) Market, By Demography

• Child Population
• Adult Population

To Get a Summarized Market Report By Demography-

Based on Demography, the market is divided into Child population and Adult population. Adult Population accounted for the largest market share of 89.19% in 2022, with a market value of USD 4,003.47 Million, and is projected to grow at the highest CAGR of 20.74% during the forecast period. Child Population was the second-largest market in 2022, valued at USD 485.39 Million in 2022; it is projected to grow at a CAGR of 23.56%.

U.S. Continuous Glucose Monitoring (CGM) Market, By Testing Type

• Stomach
• Back of the Arm

To Get a Summarized Market Report By Testing Type-

Based on Testing Type, the market is divided into Stomach and Back of the arm. Back of the Arm accounted for the largest market share of 83.13% in 2022, with a market value of USD 3,731.50 Million, and is projected to grow at a CAGR of 21.29% during the forecast period. Stomach was the second-largest market in 2022, valued at USD 757.37 Million in 2022; it is projected to grow at a CAGR of 19.98%.

U.S. Continuous Glucose Monitoring (CGM) Market, By End-Use

• Split Hospitals
• Home care
• Diagnostic Centers & Clinics
• Others

Based on End-Use, the market is Split Hospitals, Home care, Diagnostic Centers & Clinics, and Others.

Key Players

The “U.S. Continuous Glucose Monitoring (CGM) Market” study report will provide valuable insight with an emphasis on the market. The major players in the market include Abbott, Dexcom, Inc., Senseonics Holdings, Inc., Medtronic, Roche, A. Menarini Diagnostics s.r.l, Echo Therapeutics, Inc., GlySens Incorporated, LifeScan Inc., Agamatrix, Insulet Corporation, and Nemaura Medical.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• June 2023Abbott developed a new bio wearable sensor that would continually monitor glucose and ketone levels. The system has received FDA breakthrough device designation, which is intended to speed the examination of revolutionary technologies that potentially enhance the lives of patients with life-threatening or irreversibly debilitating diseases or disorders.

Report Scope

To Get Customized Report Scope- 

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.